Why don't we have a vaccine for SARS? MERS? HIV? These viruses have been around longer than SARS-CoV-2. A mini-thread to provide some perspective and even a little dose of optimism. We are not in the same situation here. 1/7
— Natalie E. Dean, PhD (@nataliexdean) May 25, 2020
This preprint on SARS-CoV-2 transmission dynamics was a great read. The discussion about heterogeneity often focuses on numbers of contacts, but that always felt incomplete to me. As much as possible, we must link the models to the biology. (Thread 1/7)https://t.co/ptE6KCbrC2pic.twitter.com/76pznbAl7w
— Natalie E. Dean, PhD (@nataliexdean) May 22, 2020
Science is our exit strategy. Driving case numbers low buys us important time to develop, test, and deploy vaccines, but there are many other important reasons to slow transmission.
